Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Operating Grant

Queen's University (Kingston, Ontario)

$124,555.00

The concurrent use of medications with opposing actions: the prevalence and impact of prescribing both anticholinergics and cholinesterase inhibitors to people with dementia

FY 2008-09

Summary
A wide variety of medications possess anticholinergic properties, meaning they block a chemical called acetylcholine in the body. The anticholinergic effects of these drugs can be especially concerning in older adults for several reasons. First, they can lead to acute urinary retention (the sudden, painful inability to void). Second, anticholinergic drugs can also interfere with memory and thinking, which is especially dangerous for older people with dementia. In fact, another group of drugs called the cholinesterase inhibitors, which are used to treat dementia, essentially have the opposite effect of anticholinergic drugs. Despite their opposing actions, anticholinergics and cholinesterase inhibitors are sometimes prescribed together. This practice may provoke serious adverse effects such as acute urinary retention and worsening confusion. We will find out how commonly these drugs with opposing actions are prescribed together, and whether this prescribing practice leads to safety problems in frail older adults with dementia. If we find evidence of harm, a policy to help alert physicians to the hazards of co-prescribing these drugs may help to limit this problem.
Program
Operating Grant
Location
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
172688
Name
Gill Sudeep S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Clinical
Prcname2
Health Services Evaluation & Interventions Research - A
Projecttitle
The concurrent use of medications with opposing actions: the prevalence and impact of prescribing both anticholinergics and cholinesterase inhibitors to people with dementia
Programtype2
Operating Grants
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$124,555
Cihrequipment2
$0
Programname2
Operating Grant
Keyworddelim
Administrative Health Care Databases; Adverse Drug Events; Clinical Pharmacology; Geriatrics; Nested Case-Control Study; Pharmacoepidemiology
Abstract
A wide variety of medications possess anticholinergic properties, meaning they block a chemical called acetylcholine in the body. The anticholinergic effects of these drugs can be especially concerning in older adults for several reasons. First, they can lead to acute urinary retention (the sudden, painful inability to void). Second, anticholinergic drugs can also interfere with memory and thinking, which is especially dangerous for older people with dementia. In fact, another group of drugs called the cholinesterase inhibitors, which are used to treat dementia, essentially have the opposite effect of anticholinergic drugs. Despite their opposing actions, anticholinergics and cholinesterase inhibitors are sometimes prescribed together. This practice may provoke serious adverse effects such as acute urinary retention and worsening confusion. We will find out how commonly these drugs with opposing actions are prescribed together, and whether this prescribing practice leads to safety problems in frail older adults with dementia. If we find evidence of harm, a policy to help alert physicians to the hazards of co-prescribing these drugs may help to limit this problem.
Competitiondate
200809
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Gill, Sudeep S
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $124,555~ $0~
Queen's University (Kingston, Ontario) - $124,555 Gra… | Canada Spends